Back to Journals » Drug Design, Development and Therapy » Volume 12

CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia

Total article views   HTML views PDF downloads Totals
38,921 Dovepress* 19,625+ 2,541 22,166
PubMed Central* 19,296 3,016 22,312
Totals 38,921 5,557 44,478
*Since 12 November 2018
Total mentioned Facebook Delicious Reddit Twitter Others
11 1 0 0 1 9

View citations on PubMed Central and Google Scholar